A review of latest clinical practice guidelines for the management of cancer-associated thrombosis
{{output}}
The management of cancer-associated thrombosis (CAT) poses unique challenges to healthcare professionals. While low-molecular weight heparins (LMWHs) have long been the gold standard for both the primary and secondary prevention of CAT, results from large rand... ...
